Explore more publications!

Eyeballs & Clicks: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Eyeballs & Clicks.

Press releases published on September 20, 2025

Narconon International Conference 2025 Celebrates Global Achievements
MC Homes Real Estate Sells Home After 4 Years and 6 Agents — at Full Asking Price
Pipimu Launches Exclusive 'Gifts for Him' Collection for Upcoming Holiday Season
Industrial 3D Printing Gases Industry Sector Trends | $19.33B in 2024 to $103.93B by 2032
Forklift Truck Market grows on Automation, Cold Storage and Logistics, reaching $142.08B by 2033 | DataM Intelligence
Studycat Makes Speech Practice Playful in its Children's Spanish Language iPhone App
Home Brewing and Lifestyle: iGulu Appliance vs. Pinter Kit
XRP-Connected Market Narratives Reference MAGACOIN FINANCE Ahead of Presale Milestones
ROSEN, A LEADING LAW FIRM, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLR
Gold IRA Rollover Guide: How to Convert an IRA or 401(k) to Gold, Explained by Clute Journals
Cardano Rival MAGACOIN FINANCE Gains Presence in Global Altcoin Commentary
Missacc Launches Its Latest Collection of Quality Formalwear at Competitive Prices
Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors – Read France Report!
Immediate Edge: Exploring the AI Technology Behind Immediate Edge Trading Platform – Germany Insights!
SLNO Investor News: If You Have Suffered Losses in Soleno Therapeutics, Inc. (NASDAQ: SLNO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
Inventor  Announces Breakthrough Continuation Patent filed for Graphene-Based Interconnects
Buck Sexton: “This Could Be the Key” — Former CIA Officer Reveals Bold Plan and China’s Dangerous Lead
Wiingy Report: Trump’s $100,000 H1B Visa Fee Opens Over Half a Million Tech Jobs to Americans
C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions